Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Mol Cancer Ther. 2012 Aug 21;11(11):2483–2494. doi: 10.1158/1535-7163.MCT-12-0580

Fig. 5.

Fig. 5

Enhanced cDDP-mediated inhibition of tumor growth by D-pen. (A) Growth rates measurements in four groups of animals. (B) Representative tumors in the treated animals from each group at the end of the treatment (circled). (C) hCtr1 and Sp1 mRNA expression in the residual tumors in each animal as determined by the RPA. (D) Statistical analyses of the hCtr1 (left) and Sp1 (right) expression results of RPA shown in (C).